
Omnax Pharmaceuticals Private Limited
About Omnax Pharmaceuticals Private Limited
Data last updated:
Omnax Pharmaceuticals Private Limited is a private limited company based in Bengaluru, Karnataka, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 23 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24239KA2021PTC145709.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sanmati Epari and Samir Kumar Patra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 471 1st Floor Anand Arcade Doddakallasandra Narayananagar 1st Block, Bengaluru, Karnataka, India – 560062.
As per the financials filed for FY 2025, the company reported a revenue of ₹58.36 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹5.15 Lakh (net margin 8.8%) and EBITDA of ₹5.16 Lakh (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.
Omnax Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0078909).
Company details
Recognitions & Rankings of Omnax Pharmaceuticals
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-KR-03-0078909
Contact details
Omnax Pharmaceuticals Private Limited's registered office is in Bengaluru, Karnataka.
- Registered AddressNo. 471 1st Floor Anand Arcade Doddakallasandra Narayananagar 1st Block, Bengaluru, Karnataka, India – 560062
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Omnax Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Omnax Pharmaceuticals Private Limited, buy the company report.
Financials of Omnax Pharmaceuticals Private Limited
FY 2025 filings availableOmnax Pharmaceuticals Private Limited reported revenue of ₹58.36 Lakh (up 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 24% over three years, including 32% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | ||||
| Net Profit Margin | 8.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Omnax Pharmaceuticals Private Limited, buy the company report.
Board of directors of Omnax Pharmaceuticals Private Limited
Omnax Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanmati Epari | Director | 23 Mar 2021 | 5 Years 7 Months | Current |
| Samir Kumar Patra | Director | 23 Mar 2021 | 5 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Omnax Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Omnax Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Omnax Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Omnax Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Samir Kumar Patra was appointed as Director on 23 Mar 2021.
Frequently asked questions
Omnax Pharmaceuticals is an active private limited company based in Bengaluru, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 23 March 2021 (5+ years old) and is registered under CIN U24239KA2021PTC145709.
Omnax Pharmaceuticals has 2 current directors:
- Sanmati Epari - Director
- Samir Kumar Patra - Director
The latest financial statements of Omnax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Omnax Pharmaceuticals is U24239KA2021PTC145709. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Omnax Pharmaceuticals was incorporated on 23 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
Samir Kumar Patra was appointed as Director on 23 Mar 2021. Sanmati Epari was appointed as Director on 23 Mar 2021.
Yes, Omnax Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Omnax Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-KR-03-0078909).
The registered office of Omnax Pharmaceuticals is at No. 471 1st Floor Anand Arcade Doddakallasandra Narayananagar 1st Block, Bengaluru, Karnataka, India – 560062.
Omnax Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

